Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Chromatogr ; 14(7): 453-8, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11113923

ABSTRACT

The electrochemical behaviour of isradipine in a mixed solution of Britton-Robinson buffer (pH 11.8):acetonitrile:methanol (6:3:1, v/v) was studied by cyclic voltammetry and spectroelectrochemistry using an optically transparent thin layer electrode of carbon cloth. The cyclic voltammogram showed several peaks whose shape and potentials depended on the pH. The peak at 330 nm, corresponding to the absorbance of the dihydropyridine ring, disappeared after electrolysis at a potential that was more positive than the oxidation peak. The oxidation peak corresponds to the oxidation of the dihydropyridine ring. Peak height at pH 11.8 was proportional to isradipine concentration. On the basis of the redox properties of isradipine, HPLC was conducted applying electrochemical detection on a polybutadiene coated alumina column using an alkaline mobile phase. The method was applied for the determination of isradipine content in human serum. A good linear relationship between isradipine concentration and peak height was found in the concentration range of 2-200 ng/mL with a correlation coefficient of 0.9924. The detection limit was 0.5 ng/mL. The within-day and day-to-day variation were examined for control human serum and percentage relative standard deviation ranged from 0.5 to 6.7. Interference from many other coadministered drugs was studied in the specified experimental conditions. Photo and heat stabilities of the compound were also studied.


Subject(s)
Antihypertensive Agents/blood , Calcium Channel Blockers/blood , Chromatography, High Pressure Liquid/methods , Isradipine/blood , Antihypertensive Agents/chemistry , Calcium Channel Blockers/chemistry , Electrochemistry , Humans , Hydrogen-Ion Concentration , Isradipine/chemistry , Reproducibility of Results , Sensitivity and Specificity
2.
Biol Pharm Bull ; 18(10): 1311-4, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8593428

ABSTRACT

Barnidipine is a 1,4-dihydropyridine calcium antagonist. HPLC was conducted on a polybutadiene coated alumina column using an alkaline mobile phase and an electrochemical detector to determine the content of this drug in serum and plasma. A good linear relationship between barnidipine concentration and peak height was found in 5-500 ng/ml with a correlation coefficient of 0.998. The detection limit was 1 ng/ml. The within-day and day-to-day variations were examined for control human serum. Relative standard deviation of within-day assay for serum spiked with 10 ng/ml barnidipine.HCl was 6.9% and the recovery was 104%. A pharmacokinetic study was made in which the time course of barnidipine in dog plasma was followed.


Subject(s)
Calcium Channel Blockers/blood , Nifedipine/analogs & derivatives , Animals , Calcium Channel Blockers/chemistry , Calcium Channel Blockers/pharmacokinetics , Chromatography, High Pressure Liquid , Dogs , Electrochemistry , Humans , Indicators and Reagents , Nifedipine/blood , Nifedipine/chemistry , Nifedipine/pharmacokinetics , Photochemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...